We are planing implant decellularized xenograft subcutaneous to stablish the inflammatory answer we follow the implant for 1,2,7 and 15 days in CD-1 mice and we do immunosatining of the implanted tissue area anti-TNFalpha and IL-1alpha, what do you think is a good approach? 

Similar questions and discussions